List of studies


Study Results

  • BI trial 1346-0011/-0012/-0013

    A phase III randomized, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of BI 425809 once daily over 26 week treatment period in patients with schizophrenia

    • Trust Name: Southern Health NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Psychosis - schizophrenia
    • Specialty: Mental Health
    • Recruitment Site: Hollybank
    Read more Return to top (preview/message buttons)
  • BI trial 1346-0011/-0012/-0013

    A phase III randomized, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of BI 425809 once daily over 26 week treatment period in patients with schizophrenia

    • Trust Name: Southern Health NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Psychosis - schizophrenia
    • Specialty: Mental Health
    • Recruitment Site: Moorgreen Hospital
    Read more Return to top (preview/message buttons)
  • BI trial 1346-0011/-0012/-0013

    A phase III randomized, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of BI 425809 once daily over 26 week treatment period in patients with schizophrenia

    • Trust Name: Southern Health NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Psychosis - schizophrenia
    • Specialty: Mental Health
    • Recruitment Site: Petersfield Hospital
    Read more Return to top (preview/message buttons)
  • BI trial 1346-0011/-0012/-0013

    A phase III randomized, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of BI 425809 once daily over 26 week treatment period in patients with schizophrenia

    • Trust Name: Southern Health NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Psychosis - schizophrenia
    • Specialty: Mental Health
    • Recruitment Site: The Parkway Centre
    Read more Return to top (preview/message buttons)
  • BI trial 1346-0011/-0012/-0013

    A phase III randomized, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of BI 425809 once daily over 26 week treatment period in patients with schizophrenia

    • Trust Name: Southern Health NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Psychosis - schizophrenia
    • Specialty: Mental Health
    • Recruitment Site: Bridge Centre
    Read more Return to top (preview/message buttons)
  • BI trial 1346-0011/-0012/-0013

    A phase III randomized, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of BI 425809 once daily over 26 week treatment period in patients with schizophrenia

    • Trust Name: Southern Health NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Psychosis - schizophrenia
    • Specialty: Mental Health
    • Recruitment Site: Cannon House
    Read more Return to top (preview/message buttons)
  • BI trial 1346-0011/-0012/-0013

    A phase III randomized, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of BI 425809 once daily over 26 week treatment period in patients with schizophrenia

    • Trust Name: Southern Health NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Psychosis - schizophrenia
    • Specialty: Mental Health
    • Recruitment Site: Chase Hospital
    Read more Return to top (preview/message buttons)
  • BI trial 1346-0011/-0012/-0013

    A phase III randomized, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of BI 425809 once daily over 26 week treatment period in patients with schizophrenia

    • Trust Name: Southern Health NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Psychosis - schizophrenia
    • Specialty: Mental Health
    • Recruitment Site: College Keep
    Read more Return to top (preview/message buttons)
  • BI trial 1346-0011/-0012/-0013

    A phase III randomized, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of BI 425809 once daily over 26 week treatment period in patients with schizophrenia

    • Trust Name: Southern Health NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Psychosis - schizophrenia
    • Specialty: Mental Health
    • Recruitment Site: Fareham & Gosport
    Read more Return to top (preview/message buttons)
  • BI trial 1346-0011/-0012/-0013

    A phase III randomized, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of BI 425809 once daily over 26 week treatment period in patients with schizophrenia

    • Trust Name: Southern Health NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Psychosis - schizophrenia
    • Specialty: Mental Health
    • Recruitment Site: Forest Lodge
    Read more Return to top (preview/message buttons)
  • 4730 EVOKE -Semaglutide in people with early Alzheimer's disease

    A randomised double-blind placebo-controlled clinical trial investigating the effect and safety of oral semaglutide in subjects with early Alzheimer´s disease (EVOKE)

    • Trust Name: Southern Health NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Dementia
    • Specialty: Dementias
    • Recruitment Site: Marc
    Read more Return to top (preview/message buttons)
  • A study of AVP-786 for agitation in patients with Alzheimer's dementia

    A Phase 3, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q]) for the treatment of agitation in patients with dementia of the Alzheimer’s type

    • Trust Name: Dorset Healthcare University NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Dementia
    • Specialty: Dementias
    • Recruitment Site: Blandford Community Hospital
    Read more Return to top (preview/message buttons)
  • BI trial 1346-0011/-0012/-0013

    A phase III randomized, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of BI 425809 once daily over 26 week treatment period in patients with schizophrenia

    • Trust Name: Southern Health NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Psychosis - schizophrenia
    • Specialty: Mental Health
    • Recruitment Site: Bitterne Park Clinic
    Read more Return to top (preview/message buttons)
  • MND Register for England, Wales and Northern Ireland

    MND Register for England, Wales and Northern Ireland

    • Trust Name: University Hospitals Dorset NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Motor neurone disease
    • Specialty: Neurological disorders
    • Recruitment Site: Poole Hospital
    Read more Return to top (preview/message buttons)
  • Phase 3 of AVP-786 in Alzheimer’s dementia patients with agitation

    A Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-design study to assess the efficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide [d6-DM]/ quinidine sulfate [Q]) for the treatment of agitation in patients with dementia of the Alzheimer’s type.

    • Trust Name: Southern Health NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Dementia
    • Specialty: Dementias
    • Recruitment Site: Marc
    Read more Return to top (preview/message buttons)
  • 4725 EVOKE plus-Semaglutide in people with early Alzheimer's disease

    A randomised double-blind placebo-controlled clinical trial investigating the effect and safety of oral semaglutide in subjects with early Alzheimer´s disease (EVOKE plus)

    • Trust Name: Southern Health NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Dementia
    • Specialty: Dementias
    • Recruitment Site: Marc
    Read more Return to top (preview/message buttons)
  • MND Register for England, Wales and Northern Ireland

    MND Register for England, Wales and Northern Ireland

    • Trust Name: University Hospital Southampton NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Motor neurone disease
    • Specialty: Neurological disorders
    • Recruitment Site: Southampton General Hospital
    Read more Return to top (preview/message buttons)
  • STRATIFY

    Brain network based stratification of reinforcement-related disorders

    • Trust Name: University Hospital Southampton NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Depression
    • Specialty: Mental Health
    • Recruitment Site: Southampton General Hospital
    Read more Return to top (preview/message buttons)
  • Genetic Links to Anxiety and Depression (GLAD)

    NIHR Mental Health BioResource for Depression and Anxiety

    • Trust Name: University Hospital Southampton NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Anxiety
    • Specialty: Mental Health
    • Recruitment Site: Southampton General Hospital
    Read more Return to top (preview/message buttons)
  • SIBIMS

    Systemic inflammation and the blood-brain barrier in multiple sclerosis.

    • Trust Name: University Hospital Southampton NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Multiple sclerosis
    • Specialty: Neurological disorders
    • Recruitment Site: Southampton General Hospital
    Read more Return to top (preview/message buttons)
  • Neuro Online Study v.1.0

    Neurological Long-term Conditions: Online Integrated Care Platform Study

    • Trust Name: University Hospital Southampton NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Multiple sclerosis
    • Specialty: Neurological disorders
    • Recruitment Site: Southampton General Hospital
    Read more Return to top (preview/message buttons)
  • OptiCALS Randomised Controlled Trial

    OptiCALS: A Randomised Controlled Trial with parallel Process Evaluation and Health Economic analysis to evaluate a nutritional management intervention, OptiCALS, for patients with Amyotrophic Lateral Sclerosis

    • Trust Name: University Hospital Southampton NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Motor neurone disease
    • Specialty: Neurological disorders
    • Recruitment Site: Southampton General Hospital
    Read more Return to top (preview/message buttons)
  • STRATIFY

    Brain network based stratification of reinforcement-related disorders

    • Trust Name: Southern Health NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Depression
    • Specialty: Mental Health
    • Recruitment Site: College Keep
    Read more Return to top (preview/message buttons)
  • Genetic Links to Anxiety and Depression (GLAD)

    NIHR Mental Health BioResource for Depression and Anxiety

    • Trust Name: Southern Health NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Anxiety
    • Specialty: Mental Health
    • Recruitment Site: Moorgreen Hospital
    Read more Return to top (preview/message buttons)
  • SIBIMS

    Systemic inflammation and the blood-brain barrier in multiple sclerosis.

    • Trust Name: Southern Health NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Multiple sclerosis
    • Specialty: Neurological disorders
    • Recruitment Site: Lymington New Forest Hospital
    Read more Return to top (preview/message buttons)
  • Genetic Links to Anxiety and Depression (GLAD)

    NIHR Mental Health BioResource for Depression and Anxiety

    • Trust Name: The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Anxiety
    • Specialty: Mental Health
    • Recruitment Site: Royal Bournemouth and Christchurch NHS Trust
    Read more Return to top (preview/message buttons)
  • ClASP-ID

    Developing the Clinical Anxiety Screen for people with Severe to Profound Intellectual Disabilities (CIASP-ID)

    • Trust Name: The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Learning disorders
    • Specialty: Mental Health
    • Recruitment Site: Royal Bournemouth and Christchurch NHS Trust
    Read more Return to top (preview/message buttons)
  • OptiCALS Randomised Controlled Trial

    OptiCALS: A Randomised Controlled Trial with parallel Process Evaluation and Health Economic analysis to evaluate a nutritional management intervention, OptiCALS, for patients with Amyotrophic Lateral Sclerosis

    • Trust Name: The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Motor neurone disease
    • Specialty: Neurological disorders
    • Recruitment Site: Royal Bournemouth and Christchurch NHS Trust
    Read more Return to top (preview/message buttons)
  • SIBIMS

    Systemic inflammation and the blood-brain barrier in multiple sclerosis.

    • Trust Name: Solent NHS Trust
    • Contact name: R&D department
    • Condition: Multiple sclerosis
    • Specialty: Neurological disorders
    • Recruitment Site: Nichols Town Surgery
    Read more Return to top (preview/message buttons)
  • OptiCALS Randomised Controlled Trial

    OptiCALS: A Randomised Controlled Trial with parallel Process Evaluation and Health Economic analysis to evaluate a nutritional management intervention, OptiCALS, for patients with Amyotrophic Lateral Sclerosis

    • Trust Name: Portsmouth Hospitals University National Health Service Trust
    • Contact name: R&D department
    • Condition: Motor neurone disease
    • Specialty: Neurological disorders
    • Recruitment Site: Queen Alexandra Hospital
    Read more Return to top (preview/message buttons)
  • MND Register for England, Wales and Northern Ireland

    MND Register for England, Wales and Northern Ireland

    • Trust Name: Salisbury NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Motor neurone disease
    • Specialty: Neurological disorders
    • Recruitment Site: Salisbury District Hospital
    Read more Return to top (preview/message buttons)
  • OptiCALS Randomised Controlled Trial

    OptiCALS: A Randomised Controlled Trial with parallel Process Evaluation and Health Economic analysis to evaluate a nutritional management intervention, OptiCALS, for patients with Amyotrophic Lateral Sclerosis

    • Trust Name: Salisbury NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Motor neurone disease
    • Specialty: Neurological disorders
    • Recruitment Site: Salisbury District Hospital
    Read more Return to top (preview/message buttons)
  • STRATIFY

    Brain network based stratification of reinforcement-related disorders

    • Trust Name: Solent NHS Trust
    • Contact name: R&D department
    • Condition: Depression
    • Specialty: Mental Health
    • Recruitment Site: St Mary's Health Campus
    Read more Return to top (preview/message buttons)
  • Genetic Links to Anxiety and Depression (GLAD)

    NIHR Mental Health BioResource for Depression and Anxiety

    • Trust Name: Solent NHS Trust
    • Contact name: R&D department
    • Condition: Anxiety
    • Specialty: Mental Health
    • Recruitment Site: St Mary's Health Campus
    Read more Return to top (preview/message buttons)
  • ClASP-ID

    Developing the Clinical Anxiety Screen for people with Severe to Profound Intellectual Disabilities (CIASP-ID)

    • Trust Name: Isle of Wight NHS Trust
    • Contact name: R&D department
    • Condition: Learning disorders
    • Specialty: Mental Health
    • Recruitment Site: St Mary's Hospital
    Read more Return to top (preview/message buttons)
  • OptiCALS Randomised Controlled Trial

    OptiCALS: A Randomised Controlled Trial with parallel Process Evaluation and Health Economic analysis to evaluate a nutritional management intervention, OptiCALS, for patients with Amyotrophic Lateral Sclerosis

    • Trust Name: Isle of Wight NHS Trust
    • Contact name: R&D department
    • Condition: Motor neurone disease
    • Specialty: Neurological disorders
    • Recruitment Site: St Mary's Hospital
    Read more Return to top (preview/message buttons)
  • MND Register for England, Wales and Northern Ireland

    MND Register for England, Wales and Northern Ireland

    • Trust Name: NHS Frimley CCG (Wessex)
    • Contact name: R&D department
    • Condition: Motor neurone disease
    • Specialty: Neurological disorders
    • Recruitment Site: Phyllis Tuckwell Mem.Hosp
    Read more Return to top (preview/message buttons)
  • MND Register for England, Wales and Northern Ireland

    MND Register for England, Wales and Northern Ireland

    • Trust Name: NHS North East Hampshire and Farnham CCG
    • Contact name: R&D department
    • Condition: Motor neurone disease
    • Specialty: Neurological disorders
    • Recruitment Site: Phyllis Tuckwell Mem.Hosp
    Read more Return to top (preview/message buttons)
  • SIBIMS

    Systemic inflammation and the blood-brain barrier in multiple sclerosis.

    • Trust Name: NHS West Hampshire CCG
    • Contact name: R&D department
    • Condition: Multiple sclerosis
    • Specialty: Neurological disorders
    • Recruitment Site: Park Surgery
    Read more Return to top (preview/message buttons)
  • MND Register for England, Wales and Northern Ireland

    MND Register for England, Wales and Northern Ireland

    • Trust Name: NIHR CRN: Wessex
    • Contact name: R&D department
    • Condition: Motor neurone disease
    • Specialty: Neurological disorders
    • Recruitment Site: Phyllis Tuckwell Mem.Hosp
    Read more Return to top (preview/message buttons)
  • Genetic Links to Anxiety and Depression (GLAD)

    NIHR Mental Health BioResource for Depression and Anxiety

    • Trust Name: Portsmouth Hospitals University National Health Service Trust
    • Contact name: R&D department
    • Condition: Anxiety
    • Specialty: Mental Health
    • Recruitment Site: Queen Alexandra Hospital
    Read more Return to top (preview/message buttons)
  • MND Register for England, Wales and Northern Ireland

    MND Register for England, Wales and Northern Ireland

    • Trust Name: Hampshire Hospitals NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Motor neurone disease
    • Specialty: Neurological disorders
    • Recruitment Site: Basingstoke and North Hampshire Hospital
    Read more Return to top (preview/message buttons)
  • Genetic Links to Anxiety and Depression (GLAD)

    NIHR Mental Health BioResource for Depression and Anxiety

    • Trust Name: Hampshire Hospitals NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Anxiety
    • Specialty: Mental Health
    • Recruitment Site: Basingstoke and North Hampshire Hospital
    Read more Return to top (preview/message buttons)
  • OptiCALS Randomised Controlled Trial

    OptiCALS: A Randomised Controlled Trial with parallel Process Evaluation and Health Economic analysis to evaluate a nutritional management intervention, OptiCALS, for patients with Amyotrophic Lateral Sclerosis

    • Trust Name: Hampshire Hospitals NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Motor neurone disease
    • Specialty: Neurological disorders
    • Recruitment Site: Basingstoke and North Hampshire Hospital
    Read more Return to top (preview/message buttons)
  • Genetic Links to Anxiety and Depression (GLAD)

    NIHR Mental Health BioResource for Depression and Anxiety

    • Trust Name: Isle of Wight NHS Trust
    • Contact name: R&D department
    • Condition: Anxiety
    • Specialty: Mental Health
    • Recruitment Site: St Mary's Hospital
    Read more Return to top (preview/message buttons)
  • Genetic Links to Anxiety and Depression (GLAD)

    NIHR Mental Health BioResource for Depression and Anxiety

    • Trust Name: Dorset Healthcare University NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Anxiety
    • Specialty: Mental Health
    • Recruitment Site: Boscombe Community Hospital
    Read more Return to top (preview/message buttons)
  • Genetic Links to Anxiety and Depression (GLAD)

    NIHR Mental Health BioResource for Depression and Anxiety

    • Trust Name: Dorset Healthcare University NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Anxiety
    • Specialty: Mental Health
    • Recruitment Site: Dorset Healthcare University NHS Foundation Trust
    Read more Return to top (preview/message buttons)
  • STRATIFY

    Brain network based stratification of reinforcement-related disorders

    • Trust Name: Dorset Healthcare University NHS Foundation Trust
    • Contact name: R&D department
    • Condition: Depression
    • Specialty: Mental Health
    • Recruitment Site: Dorset Healthcare University NHS Foundation Trust
    Read more Return to top (preview/message buttons)

Accessibility tools

Return to header